Clopidogrel Hypersensitivity: Pathogenesis, Presentation and Diagnosis

Author(s): Megan K. Ford*, John R. Cohn.

Journal Name: Current Vascular Pharmacology

Volume 17 , Issue 2 , 2019

Submit Manuscript
Submit Proposal

Graphical Abstract:


This paper provides an overview of the pathogenesis, presentation and diagnosis of clopidogrel hypersensitivity. The majority of clopidogrel hypersensitivity cases are due to a T cell mediated Gell and Coombs Type IV reaction. History, histology, and patch testing have shown consistency with a T cell mediated mechanism. Clopidogrel reactions most commonly present as a mild delayed maculopapular erythematous rash 5 to 10 days after introduction of the drug, and do not always require discontinuation of the drug. Severe cutaneous, systemic, and immediate adverse reactions to clopidogrel are rare. For the diagnosis of clopidogrel hypersensitivity, drug causality can be determined using patch testing, or for mild reactions, recurrence of symptoms after drug reintroduction, although neither are required for diagnosis.

Keywords: Clopidogrel, hypersensitivity, pathogenesis, diagnosis, clopidogrel allergy, drug allergy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2019
Page: [110 - 112]
Pages: 3
DOI: 10.2174/1570161116666181031143628
Price: $58

Article Metrics

PDF: 18